Cáncer de vesícula biliar

+ -Text Size

Otros recursos y referencias TEMAS

Referencias: guía detallada del cáncer de vesícula biliar

American Cancer Society. Cancer Facts & Figures 2014. Atlanta, Ga: American Cancer Society; 2014.

American Joint Committee on Cancer. Gallbladder. In: AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010: 211-214.

Bartlett DL, Ramanathan RK, Ben-Josef E. Cancer of the biliary tree. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011: 1019-1047.

Dixon E, Vollmer CM, Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer. Ann Surgery. 2005;241:385-394.

Fong Y, Wagman L, Gonen M, et al. Evidence-based gallbladder cancer staging: Changing cancer staging by analysis of data from the National Cancer Database. Ann Surg. 2006;243:767-771.

Gruenberger B, Schueller J, Heubrandtner U, et al. Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: A phase 2 study. Lancet Oncol. 2010;11(12):1142-1148. Epub 2010 Nov 9.

Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER Website, April 2012.

Key C, Meisner ALW. Cancer of the Liver and Biliary Tract. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J (editors). SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD, 2007.

Lazcano-Ponce EC, Miquesl JF, Munoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51:349-364.

Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence. Am J Surg Pathol. 2007;31(6):907-913.

Misra S, Chaturvedi A, Misra NC, et al. Carcinoma of the gallbladder. Lancet Oncology. 2003;4:167-176.

National Cancer Institute. Physician Data Query (PDQ). Gallbladder Cancer Treatment. 2/15/2013. Accessed at www.cancer.gov/cancertopics/pdq/treatment/gallbladder/HealthProfessional on April 11, 2013.

National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers. V.2.2012. Accessed at www.nccn.org on April 11, 2013.

Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273-1281.

Weber S, Jarnagin W, Duffy A, et al. Liver and bile duct cancer. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. Kastan MB, McKenna WG, eds. Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier; 2008: 1569-1594.

Wistuba II, Gazdar AF. Gallbladder cancer: Lessons from a rare tumor. Nature Reviews Cancer. 2004;4:695-706.


Fecha de última actualización: 07/29/2013
Fecha de último cambio o revisión: 02/06/2014